Moderna stock rallied by about 12% over the last week (five trading days) outperforming the S&P 500 which remained roughly flat over the same period. The recent gains come as the U.S. authorized booster vaccine shots for all adults, likely implying that Moderna's Covid-19 shot can be administered...
Moderna stock rallied by about 12% over the last week (five trading days) outperforming the S&P 500 which remained roughly flat over the same period. The recent gains come as the U.S. authorized booster vaccine shots for all adults, likely implying that Moderna's Covid-19 shot can be administered...
Share this Article
Recommended